作者: C CONRYCANTILENA
关键词:
摘要: Summary Permitting the use of blood from HH patients without a disease-state labeling has been controversial topic. Another issue safety blood. If otherwise qualified to be donor in US, will allowed make contributions supply if they donate at collection facility that granted an exemption their FDA license. The amount additional made available by using patient/donors is uncertain. Gathering data patients/donors regarding management, safety, and augmentation essential assessing success recent changes.